Express Scripts' service provider subsidiary United BioSource secures PE investment

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/10255185_88)
(Image: Getty/10255185_88)

Related tags Corporation Health care

Avista Capital Partners has signed an agreement to acquire United BioSource (UBC), adding another pharmaceutical service provider to the firm’s list of current and historical investments.

Headquartered in New York, Avista Capital Partners is private equity (PE) firm with approximately $6bn under management.

The company declined to comment on the acquisition of UBC, a wholly-owned subsidiary of Express Scripts, who also declined to comment.

Blue Bell, PA-headquartered UBC provides clinical, safety, and commercialization services with 13 locations in the US, Canada, and Europe.

Patrick Lindsay, UBC president, said in the press release:

"Avista's commitment to the healthcare industry makes them the ideal partner as we continue to improve patient care. Together, we will provide our clients, their patients, and their prescribers with innovative services that meet the demands of a dynamic industry​."

Investing in the healthcare sector

Avista has previously​ invested in service providers including INC Research, Charles River Laboratories, BioReliance Corporation, and Accellent, among others.

The laboratory product, supply chain, and service provider, VWR International – which was recently acquired​ by Avantor, Inc. – is listed under the firm’s current​ investments.

Given the industry’s strong fundamentals and outlook for continued growth, Avista believes the healthcare sector continues to be an attractive area for investment​,” the company states on its website.

In the press release, Rob Girardi, Partner of Avista Capital Partners, said: "We are excited to partner with UBC at this moment in the company's growth cycle, and look forward to leveraging both Avista's and UBC's expertise in the healthcare sector to deliver on the significant opportunities ahead​."

Related news

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us